The hypolipidemic activity of novel benzofuran-2-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats: a comparison with bezafibrate

References

• Epstein FM. The hepatorenal syndrome–newer perspectives. N Engl J Med 1992;327:1774–8.
   PubMed Web of Science ®Google Scholar
• Libby P, Schoenbeck U, Mach F, Selwyn AP, Ganz P. Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization. Am J Med 1998;104:18S–27S.
   PubMedGoogle Scholar
• Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet 1986;2:933–6.
   PubMed Web of Science ®Google Scholar
• West KM, Ahuja MS, Bennet PH. The role of circulating glucose and triglyceride concentrations and their interactions with other “risk factors” as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care 1983;6:361–9.
   PubMed Web of Science ®Google Scholar
• Schurr PE, Schultz JR, Parkinson TM. Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs. Lipids 1972;7:69–74.
   Web of Science ®Google Scholar
• Hayashi H, Niinobe S, Matsumoto Y, Suga T. Effects of Triton WR-1339 on lipoprotein lipolytic activity and lipid content of rat liver lysosomes. J Biochem 1981;89:573–9.
   PubMed Web of Science ®Google Scholar
• Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987;317:1237–45.
   PubMed Web of Science ®Google Scholar
• Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999;341:410–18.
   PubMed Web of Science ®Google Scholar
• Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 1996;37:907–25.
   PubMed Web of Science ®Google Scholar
• Ross BC, Middlemiss D, Scopes D, Jack T, Cardwell K, Dowle M, et al. Benzofuran derivatives. US Patent 5498722, May 15, 1992.
   Google Scholar
• Holzemann G, Schiemann K, Bottcher H, Heinrich T, Seyfried C, Leibrock J, et al. Benzofuran oxyethylamines as antidepressants and anxiolytics. US Patent 7425574, September 16, 2008.
   Google Scholar
• Parker RA. Alkoxy benzofuran carboxylic acids and salts and esters thereof as hypolipidemic agents. US Patent 4229467, October 21, 1980.
   Google Scholar
• Sohda T, Odaka H, Momose Y. Benzofuran compounds and their use. US Patent 5723479, March 3, 1998.
   Google Scholar
• Kellner A, Correll JW, Ladd AT. The influence of intravenously administered surface-active agents on the development of experimental atherosclerosis in rabbits. J Exp Med 1951;93:385–98.
   PubMed Web of Science ®Google Scholar
• Ohmori K, Yamada H, Yasuda A, Yamamoto A, Matsuura N, Kiniwa M. Effects of a novel anti-hyperlipidemic agent, S-2E, on blood lipid levels in rats with fructose-induced hypertriglyceridemia. Pharmacology 2004;72:240–6.
   PubMed Web of Science ®Google Scholar
• Harnafi H, Bouanani N, Aziz M, Serghini H, Ghalim N, Amrani S. The hypolipidaemic activity of aqueous Erica multiflora flowers extract in Triton WR-1339 induced hyperlipidaemic rats: a comparison with fenofibrate. J Ethnopharmacol 2007;109:156–60.
   PubMed Web of Science ®Google Scholar
• Lauk L, Galati EM, Forestieri AM, Kirjavainen S, Trovato A. Mucuma pruriens infusion lowers cholesterol and total lipid plasma levels in the rat. Phytother Res 1989;3:263–4.
   Web of Science ®Google Scholar
• Khanna AK, Chauder R, Chandan S, Srivastava AK, Kapoor NK. Hypolipidemic activity of Achyranthus aspera Linn in normal and Triton induced hyperlipemic rats. Indian J Exp Biol 1992;30:128–30.
   PubMedGoogle Scholar
• Yamamoto K, Byrne R, Edelstein C, Shen B, Scanu AM. In vitro effect of Triton WR-1339 on canine plasma high density lipoproteins. J Lipid Res 1984;25:770–9.
   PubMed Web of Science ®Google Scholar
• Otway S, Robinson DS. The use of a non-ionic detergent (Triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions. J Physiol 1967;190:309–19.
   PubMed Web of Science ®Google Scholar
• Campillo JE, Torres MD, Dominguez E, Romero A, Perez C. Ficus carica leaf administration reduces hypertrygliceridaemia in streptozotocin diabetic rats. Diabetologia 1994;37:A213.
   Google Scholar
• Perez C, Canal JR, Campello JE, Adelaida R, Torres MD. Hypotriglyceridaemic activity of Ficus carica leaves in experimental hypertriglyceridaemic rats. Phytother Res 1999;13:188–91.
   PubMed Web of Science ®Google Scholar
• Khanna AK, Rizvi F, Chander R. Lipid lowering activity of Phyllanthus niruri in hyperlipemic rats. J Ethnopharmacol 2002;82:19–22.
   PubMed Web of Science ®Google Scholar
• Malloy MJ, Kan JP. Medical management of hyperlipidemic states. Adv Intern Med 1994;39:603–31.
   PubMedGoogle Scholar
• Anila L, Vijayalakshmi NR. Flavonoids from Emblica officinalis and Mangifera indicia - effectiveness for dyslipidemia. J Ethnopharmacol 2002;79:81–7.
   PubMed Web of Science ®Google Scholar
• Staels B, Dallongville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 1998;98:2088–93.
   PubMed Web of Science ®Google Scholar